EFFECTS OF ANTIESTROGENS ON BONE IN CASTRATED AND INTACT FEMALE RATS

被引:275
作者
JORDAN, VC
PHELPS, E
LINDGREN, JU
机构
[1] KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT ORTHOPED SURG,S-14186 HUDDINGE,SWEDEN
[2] UNIV WISCONSIN HOSP & CLIN,DEPT SURG,DIV ORTHOPED SURG,MADISON,WI 53792
关键词
antiestrogens; bone density; keoxifene; osteoporosis; tamoxifen;
D O I
10.1007/BF01806132
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of the antiestrogens tamoxifen and keoxifene on the bone density of intact and ovariectomized female rats were determined after 4 months of therapy. The antiestrogens did not cause a decrease in bone density in intact animals, although uterine wet weight did decrease. Ovariectomy caused an increase in body weight (25%) and a significant decrease in femur density (P<0.01). Antiestrogens did not further decrease the bone density of ovariectomized rats but rather helped to maintain bone density. Antiestrogens as well as estrogen (oral estradiol benzoate 25 μg daily) helped to maintain bone density in the range observed for the intact rats, but inhibited estrogen stimulation of uterine weight. These contrasting pharmacological actions of antiestrogens suggest that patients receiving long-term adjuvant tamoxifen therapy for breast cancer should be evaluated to determine whether tamoxifen can retard the development of osteoporosis. © 1987 Martinus Nijhoff Publishers.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 21 条
[1]   OSTEOPOROSIS AFTER OOPHORECTOMY IN MATURE FEMALE RAT AND EFFECT OF ESTROGEN AND/OR PROGESTOGEN REPLACEMENT THERAPY IN ITS PREVENTION [J].
AITKEN, JM ;
ARMSTRON.E ;
ANDERSON, JB .
JOURNAL OF ENDOCRINOLOGY, 1972, 55 (01) :79-&
[2]  
BAUM M, 1985, LANCET, V1, P836
[3]  
BEALL PT, 1985, CALCIFIED TISSUE INT, V36, P123
[4]   ANTAGONISM OF ESTROGEN ACTION WITH A NEW BENZOTHIOPHENE DERIVED ANTI-ESTROGEN [J].
BLACK, LJ ;
JONES, CD ;
FALCONE, JF .
LIFE SCIENCES, 1983, 32 (09) :1031-1036
[5]  
Clark JH, 1982, PHARMACOL THERAPEUT, V15, P467
[6]   ADJUVANT TAMOXIFEN TREATMENT OF ELDERLY WOMEN WITH STAGE-II BREAST-CANCER - A DOUBLE-BLIND COMPARISON WITH PLACEBO [J].
CUMMINGS, FJ ;
GRAY, R ;
DAVIS, TE ;
TORMEY, DC ;
HARRIS, JE ;
FALKSON, G ;
ARSENEAU, J .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :324-329
[7]   TREATMENT OF PRIMARY BREAST-CANCER WITH CHEMOTHERAPY AND TAMOXIFEN [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
WOLMARK, N ;
WITTLIFF, J ;
FISHER, ER ;
PLOTKIN, D ;
BOWMAN, D ;
SACHS, S ;
WOLTER, J ;
FRELICK, R ;
DESSER, R ;
LICALZI, N ;
GEGGIE, P ;
CAMPBELL, T ;
ELIAS, EG ;
PRAGER, D ;
KOONTZ, P ;
VOLK, H ;
DIMITROV, N ;
GARDNER, B ;
LERNER, H ;
SHIBATA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (01) :1-6
[8]   THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].
FURR, BJA ;
JORDAN, VC .
PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205
[9]  
GOTTARDIS MM, 1987, CANCER RES, V47, P4020
[10]  
GUSBERG SB, 1967, OBSTET GYNECOL, V30, P287